209 related articles for article (PubMed ID: 33839456)
1. Role of AMPK and Akt in triple negative breast cancer lung colonization.
Johnson J; Chow Z; Lee E; Weiss HL; Evers BM; Rychahou P
Neoplasia; 2021 Apr; 23(4):429-438. PubMed ID: 33839456
[TBL] [Abstract][Full Text] [Related]
2. Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer.
Johnson J; Chow Z; Napier D; Lee E; Weiss HL; Evers BM; Rychahou P
Cells; 2020 May; 9(5):. PubMed ID: 32438621
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of endothelin receptor B inhibits the progression of triple-negative breast cancer.
Gu X; Han S; Cui M; Xue J; Ai L; Sun L; Zhu X; Wang Y; Liu C
Ann N Y Acad Sci; 2019 Jul; 1448(1):5-18. PubMed ID: 30900271
[TBL] [Abstract][Full Text] [Related]
5. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer.
Chan SH; Kuo WH; Wang LH
J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106
[TBL] [Abstract][Full Text] [Related]
6. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
7. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
[TBL] [Abstract][Full Text] [Related]
8. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
[TBL] [Abstract][Full Text] [Related]
9. Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer.
Humphries BA; Cutter AC; Buschhaus JM; Chen YC; Qyli T; Palagama DSW; Eckley S; Robison TH; Bevoor A; Chiang B; Haley HR; Sahoo S; Spinosa PC; Neale DB; Boppisetti J; Sahoo D; Ghosh P; Lahann J; Ross BD; Yoon E; Luker KE; Luker GD
Breast Cancer Res; 2020 Jun; 22(1):60. PubMed ID: 32503622
[TBL] [Abstract][Full Text] [Related]
10. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
11. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
Jabbarzadeh Kaboli P; Luo S; Chen Y; Jomhori M; Imani S; Xiang S; Wu Z; Li M; Shen J; Zhao Y; Wu X; Hin Cho C; Xiao Z
Gene; 2022 Mar; 816():146171. PubMed ID: 35026293
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.
Cao W; Li J; Hao Q; Vadgama JV; Wu Y
Breast Cancer Res; 2019 Feb; 21(1):29. PubMed ID: 30791936
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.
You KS; Yi YW; Kwak SJ; Seong YS
Int J Oncol; 2018 Mar; 52(3):828-840. PubMed ID: 29344641
[TBL] [Abstract][Full Text] [Related]
15. The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer.
Huang SP; Liu PY; Kuo CJ; Chen CL; Lee WJ; Tsai YH; Lin YF
J Hematol Oncol; 2017 Jun; 10(1):114. PubMed ID: 28576130
[TBL] [Abstract][Full Text] [Related]
16. Targeting Akt3 signaling in triple-negative breast cancer.
Chin YR; Yoshida T; Marusyk A; Beck AH; Polyak K; Toker A
Cancer Res; 2014 Feb; 74(3):964-73. PubMed ID: 24335962
[TBL] [Abstract][Full Text] [Related]
17. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis.
Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S
Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829
[TBL] [Abstract][Full Text] [Related]
18. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
[TBL] [Abstract][Full Text] [Related]
19. Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein.
Procopio C; Andreozzi F; Laratta E; Cassese A; Beguinot F; Arturi F; Hribal ML; Perticone F; Sesti G
Endocrinology; 2009 Aug; 150(8):3584-93. PubMed ID: 19359389
[TBL] [Abstract][Full Text] [Related]
20. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
